-
|
MNPR
|
Monopar Therapeutics Inc. Common Stock
|
XNAS |
CS
|
$499.46M |
-
|
MLTX
|
MoonLake Immunotherapeutics Class A Ordinary Shares
|
XNAS |
CS
|
$753.11M |
|
-
|
EDGE
|
MRBL Enhanced Equity ETF
|
BATS |
ETF
|
- |
-
|
MURA
|
Mural Oncology plc Ordinary Shares
|
XNAS |
CS
|
$36.21M |
|
-
|
MBIO
|
Mustang Bio, Inc.
|
XNAS |
CS
|
$8.83M |
|
-
|
NNVC
|
NanoViricides Inc.
|
XASE |
CS
|
$32.07M |
-
|
NATR
|
Nature's Sunshine Products Inc.
|
XNAS |
CS
|
$313.52M |
-
|
NKTR
|
Nektar Therapeutics
|
XNAS |
CS
|
$1.06B |
|
-
|
NTHI
|
NeOnc Technologies Holdings, Inc. Common Stock
|
XNAS |
CS
|
$195.10M |
|
-
|
NEUP
|
Neuphoria Therapeutics Inc. Common Stock
|
XNAS |
ADRC
|
$9.67M |
-
|
NGNE
|
Neurogene, Inc. Common Stock
|
XNAS |
CS
|
$381.77M |
-
|
NAMS
|
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
XNAS |
CS
|
$4.17B |
-
|
NAMSW
|
NewAmsterdam Pharma Company N.V. Warrant
|
XNAS |
WARRANT
|
- |
-
|
NXTC
|
NextCure, Inc. Common Stock
|
XNAS |
CS
|
$23.98M |
-
|
NKTX
|
Nkarta, Inc. Common Stock
|
XNAS |
CS
|
$139.21M |
-
|
NBY
|
NovaBay Pharmaceuticals, Inc.
|
XASE |
CS
|
$6.37M |
-
|
NRXP
|
NRX Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$58.24M |
-
|
NRXPW
|
NRX Pharmaceuticals, Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
NRIX
|
Nurix Therapeutics, Inc. Common stock
|
XNAS |
CS
|
$1.25B |
-
|
NUVL
|
Nuvalent, Inc. Class A Common Stock
|
XNAS |
CS
|
$6.79B |
|
-
|
NUVB
|
Nuvation Bio Inc.
|
XNYS |
CS
|
$1.62B |
|
-
|
NUVB.WS
|
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
|
XNYS |
WARRANT
|
- |
-
|
NVCT
|
Nuvectis Pharma, Inc. Common Stock
|
XNAS |
CS
|
$157.28M |
-
|
OCUL
|
Ocular Therapeutix, Inc.
|
XNAS |
CS
|
$2.31B |
-
|
OLMA
|
Olema Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$573.10M |
-
|
OMER
|
Omeros Corporation
|
XNAS |
CS
|
$448.49M |
-
|
ONCO
|
Onconetix, Inc. Common Stock
|
XNAS |
CS
|
$4.26M |
-
|
OKUR
|
OnKure Therapeutics, Inc. Class A Common Stock
|
XNAS |
CS
|
$39.78M |
-
|
OPK
|
Opko Health Inc.
|
XNAS |
CS
|
$1.03B |
|
-
|
IRD
|
Opus Genetics, Inc. Common Stock
|
XNAS |
CS
|
$119.82M |
-
|
OGEN
|
Oragenics Inc.
|
XASE |
CS
|
$4.61M |
-
|
ORMP
|
Oramed Pharmaceuticals Inc.
|
XNAS |
CS
|
$87.27M |
-
|
ORGO
|
Organogenesis Holdings Inc. Class A Common Stock
|
XNAS |
CS
|
$714.52M |
-
|
OGN
|
Organon & Co.
|
XNYS |
CS
|
$1.76B |
-
|
ORIC
|
Oric Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$1.20B |
-
|
ORKA
|
Oruka Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$1.34B |
-
|
OSTX
|
OS Therapies Incorporated
|
XASE |
CS
|
$61.70M |
-
|
OVID
|
Ovid Therapeutics Inc. Common Stock
|
XNAS |
CS
|
$93.86M |
-
|
PCRX
|
Pacira BioSciences, Inc. Common Stock
|
XNAS |
CS
|
$948.62M |
-
|
PVLA
|
Palvella Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$860.77M |
-
|
KTTA
|
Pasithea Therapeutics Corp. Common Stock
|
XNAS |
CS
|
$5.14M |
-
|
KTTAW
|
Pasithea Therapeutics Corp. Warrants
|
XNAS |
WARRANT
|
- |
-
|
PDSB
|
PDS Biotechnology Corporation Common Stock
|
XNAS |
CS
|
$42.82M |
-
|
PEPG
|
PepGen Inc. Common Stock
|
XNAS |
CS
|
$317.57M |
-
|
PTIX
|
Performance Technologies Inc
|
XNAS |
CS
|
$3.97M |
-
|
PRGO
|
PERRIGO COMPANY PLC
|
XNYS |
CS
|
$1.99B |
-
|
PFE
|
Pfizer Inc.
|
XNYS |
CS
|
$138.90B |
-
|
PHAT
|
Phathom Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$942.58M |
-
|
PAHC
|
Phibro Animal Health Corporation Class A
|
XNAS |
CS
|
$1.77B |
-
|
PHIO
|
Phio Pharmaceuticals Corp. Common Stock
|
XNAS |
CS
|
$8.93M |
-
|
PLRX
|
Pliant Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$98.22M |
-
|
ELAB
|
PMGC Holdings Inc. Common Stock
|
XNAS |
CS
|
$4.04M |
-
|
PMVP
|
PMV Pharmaceuticals, Inc
|
XNAS |
CS
|
$69.42M |
-
|
PRAX
|
Praxis Precision Medicines, Inc. Common Stock
|
XNAS |
CS
|
$4.21B |
-
|
PGEN
|
Precigen, Inc. Common Stock
|
XNAS |
CS
|
$1.38B |
-
|
PRLD
|
Prelude Therapeutics Incorporated
|
XNAS |
CS
|
$67.35M |
-
|
PBH
|
Prestige Consumer Healthcare Inc.
|
XNYS |
CS
|
$2.88B |
-
|
PCSA
|
Processa Pharmaceuticals, Inc. Common
|
XNAS |
CS
|
$17.07M |
-
|
PMN
|
ProMIS Neurosciences Inc. Common Shares (ON)
|
XNAS |
CS
|
$20.39M |
|
-
|
PPCB
|
Propanc Biopharma, Inc. Common Stock
|
XNAS |
CS
|
$13.19M |
-
|
PRPH
|
ProPhase Labs, Inc. Common Stock (DE)
|
XNAS |
CS
|
$11.74M |
-
|
PTIXW
|
Protagenic Therapeutics, Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
PTGX
|
Protagonist Therapeutics, Inc
|
XNAS |
CS
|
$4.97B |
-
|
PRTA
|
Prothena Corporation plc Ordinary Shares
|
XNAS |
CS
|
$568.44M |
-
|
PTCT
|
PTC Therapeutics, Inc.
|
XNAS |
CS
|
$5.76B |
-
|
PULM
|
Pulmatrix, Inc. Common Stock
|
XNAS |
CS
|
$17.71M |
-
|
PBYI
|
PUMA BIOTECHNOLOGY INC
|
XNAS |
CS
|
$301.84M |
-
|
PYXS
|
Pyxis Oncology, Inc. Common Stock
|
XNAS |
CS
|
$243.45M |
-
|
QTTB
|
Q32 Bio Inc. Common Stock
|
XNAS |
CS
|
$27.57M |
-
|
QLGN
|
Qualigen Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$5.08M |
-
|
QNRX
|
Quoin Pharmaceuticals, Ltd. American Depositary Shares
|
XNAS |
ADRC
|
$5.44M |
-
|
RFL
|
Rafael Holdings, Inc. Class B Common Stock
|
XNYS |
CS
|
$66.78M |
-
|
RFL.WS
|
Rafael Holdings, Inc. Warrants to Purchase Shares of Class B Common Stock
|
XNYS |
WARRANT
|
- |
-
|
RLYB
|
Rallybio Corporation Common Stock
|
XNAS |
CS
|
$26.13M |
-
|
RANI
|
Rani Therapeutics Holdings, Inc. Class A Common Stock
|
XNAS |
CS
|
$197.03M |
|
-
|
RAPP
|
Rapport Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$1.22B |
-
|
RAPT
|
RAPT Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$799.74M |
-
|
REGN
|
Regeneron Pharmaceuticals Inc
|
XNAS |
CS
|
$69.11B |
|
-
|
RNTX
|
Rein Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$41.45M |
-
|
RLMD
|
Relmada Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$87.96M |
-
|
RNXT
|
RenovoRx, Inc. Common Stock
|
XNAS |
CS
|
$35.24M |
-
|
RPTX
|
Repare Therapeutics Inc. Common Shares
|
XNAS |
CS
|
$72.60M |
-
|
REVB
|
Revelation Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$2.29M |
-
|
REVBW
|
Revelation Biosciences, Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
RVPH
|
Reviva Pharmaceuticals Holdings, Inc. Common Stock
|
XNAS |
CS
|
$57.52M |
-
|
RVPHW
|
Reviva Pharmaceuticals Holdings, Inc. Warrants
|
XNAS |
WARRANT
|
- |
-
|
RZLT
|
Rezolute, Inc. Common Stock (NV)
|
XNAS |
CS
|
$997.75M |
-
|
RYTM
|
Rhythm Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$6.69B |
-
|
RIGL
|
Rigel Pharmaceuticals Inc. (New)
|
XNAS |
CS
|
$638.75M |
-
|
RCKT
|
Rocket Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$343.06M |
-
|
RCKTW
|
Rocket Pharmaceuticals, Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
RMTI
|
Rockwell Medical, Inc. (DE) Common Stock
|
XNAS |
CS
|
$33.93M |
-
|
ROIV
|
Roivant Sciences Ltd. Common Shares
|
XNAS |
CS
|
$14.08B |
-
|
RPRX
|
Royalty Pharma plc Class A Ordinary Shares
|
XNAS |
CS
|
$16.47B |
-
|
SGMT
|
Sagimet Biosciences Inc. Series A Common Stock
|
XNAS |
CS
|
$244.56M |
-
|
SLRX
|
Salarius Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$2.57M |
-
|
SRPT
|
Sarepta Therapeutics,, Inc. Common Stock
|
XNAS |
CS
|
$1.85B |
|
-
|
SVRA
|
Savara Inc.
|
XNAS |
CS
|
$795.15M |
-
|
SDGR
|
Schrodinger, Inc. Common Stock
|
XNAS |
CS
|
$1.31B |
-
|
SCNX
|
Scienture Holdings, Inc. Common Stock
|
XNAS |
CS
|
$25.32M |